Coventry

Argus' David Toung reiterated Express Scripts Holding Company (NASDAQ: ESRX)'s Hold rating after forecasting slow prescription growth for the company. The analyst acknowledged the company's hike on 2016 EPS guidance, but noted the increase was mainly driven by a lower share count rather than a...